Study finds among outpatients with mild to moderate COVID-19, treatment with fluvoxamine does not reduce duration of symptoms

  • Post author:
  • Post category:uncategorized

Researchers investigate the effects of high-dose fluvoxamine among patients with mild-to-moderate COVID-19.